Anthacyclines in non-small cell lung cancer

被引：0
|
作者：
Pronzato, P [1 ]
Vigani, A
Tognoni, A
Vaira, F
Canessa, P
机构：
[1] Osped S Angrea, Dept Med Oncol, I-19100 La Spezia, Italy
[2] Osped S Andrea, Dept Pneumol, I-19100 La Spezia, Italy
来源：
LUNG CANCER | 2001年 / 34卷
关键词：
non-small cell lung cancer; chemotherapy; anthracyclines;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The literature concerning the use of anthracyclines in the treatment of non-small cell lung cancer (NSCLC) is reviewed here. Overall. the activity of doxorubicin (DOXO) is unsatisfactory, whereas, the analogous epidoxorubicin (EPI) yields a 30% response rate (RR) when administered at intermediate-high doses. All active drugs, including EPI. should be considered to design the most active combination. Mainly. in the setting. in which an objective response is very important. for instance the neo-adjuvant pre-operatory setting. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码：S57 / S59
页数：3
相关论文
共 50 条
  • [21] METASTASE IN NON-SMALL CELL LUNG CANCER
    Luan Van Pham
    Tien Dinh Nguyen
    Hai Minh Nguyen
    Tien Dao Nguyen
    Duyen Thi Thi
    Son Van Nguyen
    Dai Van Tran
    RESPIROLOGY, 2019, 24 : 272 - 272
  • [22] Docetaxel and non-small cell lung cancer
    Le Guen, Y
    Le Cesne, A
    BULLETIN DU CANCER, 2004, 91 (03) : 263 - 270
  • [23] Paclitaxel for non-small cell lung cancer
    Ramalingam, S
    Belani, CP
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (08) : 1771 - 1780
  • [24] Bevacizumab in non-small cell lung cancer
    Di Costanzo, Francesco
    Mazzoni, Francesca
    Mela, Marinella Micol
    Antonuzzo, Lorenzo
    Checcacci, Daniele
    Saggese, Matilde
    Di Costanzo, Federica
    DRUGS, 2008, 68 (06) : 737 - 746
  • [25] Sorafenib in non-small cell lung cancer
    Zhang, Jianjun
    Gold, Kathryn A.
    Kim, Edward
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (09) : 1417 - 1426
  • [26] Non-small cell lung cancer in the elderly
    Makrantonakis, PD
    Galani, E
    Harper, PG
    ONCOLOGIST, 2004, 9 (05): : 556 - 560
  • [27] NON-SMALL CELL LUNG-CANCER
    HASKELL, CM
    HOLMES, EC
    DM DISEASE-A-MONTH, 1988, 34 (02): : 55 - 108
  • [28] Radiotherapy of non-small cell lung cancer
    Jassem, J
    8TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2002, : 207 - 214
  • [29] Bevacizumab in Non-Small Cell Lung Cancer
    Francesco Di Costanzo
    Francesca Mazzoni
    Marinella Micol Mela
    Lorenzo Antonuzzo
    Daniele Checcacci
    Matilde Saggese
    Federica Di Costanzo
    Drugs, 2008, 68 : 737 - 746
  • [30] Radiotherapy of non-small cell lung cancer
    Kleine, P.
    Flentje, M.
    PNEUMOLOGE, 2016, 13 (04): : 241 - +
12345